Allowing clozapine access ‘closer to home’


PBAC recommends change to facilitate patients obtaining supply from a community pharmacy sooner after discharge, rather than having to attend a hospital pharmacy Community pharmacies may soon be facilitating clozapine supply for more recently discharged patients. The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended proposed changes to shorten the initial treatment period under the Section

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Email compromise the top cyber threat: underwriter
Next AI needs patient-level data to be 'clinically useful': study